Advances in the molecular pathobiology of B-lymphoblastic leukemia

Human Pathology

Volumn 43, Issue 9, 2012, Pages 1347-1362

  Zhou, Yi ^a   You, M James ^a   Young, Ken H ^a   Lin, Pei ^a   Lu, Gary ^a   Medeiros, L Jeffrey ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

B cell development; B lymphoblastic leukemia; Clonal evolution; Genomic; Molecular pathology

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD15 ANTIGEN; CD19 ANTIGEN; CD200 ANTIGEN; CD22 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA NUCLEOTIDYLEXOTRANSFERASE; ERYTHROPOIETIN RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 7 RECEPTOR ALPHA; JANUS KINASE; MICRORNA; MICRORNA 125B1; MICROSOMAL AMINOPEPTIDASE; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN KINASE SYK; PROTEIN KINASE TYK2; PROTEIN MCL 1; RETICULIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ANTIGEN EXPRESSION; B LYMPHOCYTE DIFFERENTIATION; CANCER PROGNOSIS; CELL MATURATION; CELL SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 21; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COPY NUMBER VARIATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC ASSOCIATION; HEPATOSPLENOMEGALY; HETEROZYGOSITY LOSS; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA RELAPSE; LEUKEMOGENESIS; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; METAPHASE; NEUTROPENIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETICULOCYTE COUNT; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR NECROSIS;

EID: 84864284051     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.02.004     Document Type: Article

References (132)

1. P. Lin, D. Jones, and D.M. Dorfman Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement Am J Surg Pathol 24 2000 1480 1490
2. N.L. Harris, E.S. Jaffe, and H. Stein A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392 (Pubitemid 24273002)
3. S. Faderl, S. Jeha, and H.M. Kantarjian The biology and therapy of adult acute lymphoblastic leukemia Cancer 98 2003 1337 1354 (Pubitemid 37151487)
4. J.P. Wallis, and M.M. Reid Bone marrow fibrosis in childhood acute lymphoblastic leukaemia J Clin Pathol 42 1989 1253 1254 (Pubitemid 20035909)
5. J.F. Kiraly III, and M.S. Wheby Bone marrow necrosis Am J Med 60 1976 361 368
6. M.J. Borowitz, J. Shuster, and A.J. Carroll Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study Blood 89 1997 3960 3966 (Pubitemid 27220939)
7. D.A. Thomas, S. O'Brien, and J.L. Jorgensen Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia Blood 113 2009 6330 6337
8. M.F. Greaves, L.C. Chan, and A.J. Furley Lineage promiscuity in hemopoietic differentiation and leukemia Blood 67 1986 1 11 (Pubitemid 16167003)
9. M.A. Vasef, R.K. Brynes, and J.L. Murata-Collins Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults Am J Clin Pathol 110 1998 143 149 (Pubitemid 28357651)
10. + cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy Am J Clin Pathol 110 1998 313 320 (Pubitemid 28406988)
11. J. Serrano, J. Roman, and J. Sanchez Myeloperoxidase gene expression in acute lymphoblastic leukaemia Br J Haematol 97 1997 841 843 (Pubitemid 27321385)
12. T. Ikawa, H. Kawamoto, and L.Y. Wright Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent Immunity 20 2004 349 360 (Pubitemid 38388236)
13. A. Dakic, D. Metcalf, and L. Di Rago PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis J Exp Med 201 2005 1487 1502 (Pubitemid 40664092)
14. T. Yoshida, S.Y. Ng, and J.C. Zuniga-Pflucker Early hematopoietic lineage restrictions directed by Ikaros Nat Immunol 7 2006 382 391
15. R.P. DeKoter, and H. Singh Regulation of B lymphocyte and macrophage development by graded expression of PU.1 Science 288 2000 1439 1441
16. G. Bain, E.C. Maandag, and D.J. Izon E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements Cell 79 1994 885 892 (Pubitemid 24371978)
17. D. Reynaud, I.A. Demarco, and K.L. Reddy Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros Nat Immunol 9 2008 927 936
18. Y. Zhuang, P. Soriano, and H. Weintraub The helix-loop-helix gene E2A is required for B cell formation Cell 79 1994 875 884 (Pubitemid 24371977)
19. K. Kwon, C. Hutter, and Q. Sun Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development Immunity 28 2008 751 762
20. C. Cobaleda, W. Jochum, and M. Busslinger Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors Nature 449 2007 473 477 (Pubitemid 47509547)
21. J.M. Pongubala, D.L. Northrup, and D.W. Lancki Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5 Nat Immunol 9 2008 203 215
22. L.H. Bussmann, A. Schubert, and T.P. Vu Manh A robust and highly efficient immune cell reprogramming system Cell Stem Cell 5 2009 554 566
23. C.G. Mullighan, S. Goorha, and I. Radtke Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Nature 446 2007 758 764 (Pubitemid 46582031)
24. K. Kikuchi, A.Y. Lai, and C.L. Hsu IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF J Exp Med 201 2005 1197 1203 (Pubitemid 40629064)
25. L. Hennighausen, and G.W. Robinson Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Genes Dev 22 2008 711 721 (Pubitemid 351439101)
26. S. Hirokawa, H. Sato, and I. Kato EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells Eur J Immunol 33 2003 1824 1829 (Pubitemid 37120853)
27. S. Dias, H. Silva Jr., and A. Cumano Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors J Exp Med 201 2005 971 979 (Pubitemid 40524466)
28. S. Malin, S. McManus, and C. Cobaleda Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development Nat Immunol 11 2010 171 179
29. A.J. Marshall, H.E. Fleming, and G.E. Wu Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression J Immunol 161 1998 6038 6045 (Pubitemid 28535973)
30. H.E. Fleming, and C.J. Paige Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway Immunity 15 2001 521 531 (Pubitemid 33016438)
31. D. Kitamura, J. Roes, and R. Kuhn A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene Nature 350 1991 423 426 (Pubitemid 21912244)
32. Y. Minegishi, E. Coustan-Smith, and Y.H. Wang Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia J Exp Med 187 1998 71 77 (Pubitemid 28044821)
33. M. Turner, P.J. Mee, and P.S. Costello Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk Nature 378 1995 298 302
34. H. Jumaa, L. Bossaller, and K. Portugal Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia Nature 423 2003 452 456 (Pubitemid 36626998)
35. M.J. Parker, S. Licence, and L. Erlandsson The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription EMBO J 24 2005 3895 3905 (Pubitemid 41637996)
36. J. Zhang, C.G. Mullighan, and R.C. Harvey Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group Blood 118 2011 3080 3087
37. M.P. Kamps, C. Murre, and X.H. Sun A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL Cell 60 1990 547 555
38. K.S. Smith, S.K. Chanda, and M. Lingbeek Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1 Mol Cell 12 2003 393 400 (Pubitemid 37238926)
39. I.K. Park, D. Qian, and M. Kiel Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells Nature 423 2003 302 305 (Pubitemid 40852701)
40. J. de Boer, J. Yeung, and J. Ellu The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors Leukemia 25 2011 321 330
41. K. Hirose, T. Inukai, and J. Kikuchi Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19) Blood 116 2010 962 970
42. A.V. Moorman, H.M. Ensor, and S.M. Richards Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial Lancet Oncol 11 2010 429 438
43. C.S. Huettner, P. Zhang, and R.A. Van Etten Reversibility of acute B-cell leukaemia induced by BCR-ABL1 Nat Genet 24 2000 57 60 (Pubitemid 30041421)
44. Y. Hu, Y. Liu, and S. Pelletier Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia Nat Genet 36 2004 453 461 (Pubitemid 38620028)
45. L.M. Secker-Walker, H.G. Prentice, and J. Durrant Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party Br J Haematol 96 1997 601 610 (Pubitemid 27087248)
46. H. Rieder, W.D. Ludwig, and W. Gassmann Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia Br J Haematol 95 1996 678 691 (Pubitemid 26423372)
47. A.V. Moorman, L. Chilton, and J. Wilkinson A population-based cytogenetic study of adults with acute lymphoblastic leukemia Blood 115 2010 206 214
48. C. Meyer, E. Kowarz, and J. Hofmann New insights to the MLL recombinome of acute leukemias Leukemia 23 2009 1490 1499
49. W. Chen, Q. Li, and W.A. Hudson A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy Blood 108 2006 669 677 (Pubitemid 44061369)
50. M. Metzler, A. Forster, and R. Pannell A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology Oncogene 25 2006 3093 3103 (Pubitemid 43881551)
51. + cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia Blood 117 2011 4746 4758
52. A. Bursen, K. Schwabe, and B. Ruster The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4 Blood 115 2010 3570 3579
53. M. Wetzler, R.K. Dodge, and K. Mrozek Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience Blood 93 1999 3983 3993 (Pubitemid 29249848)
54. R. Pieters, M. Schrappe, and P. De Lorenzo A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial Lancet 370 2007 240 250 (Pubitemid 47082422)
55. G. Tang, Z. Zuo, and D.A. Thomas B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related? Haematologica 2011 [Epub ahead of print]
56. L.M. Secker-Walker, and H.G. Prentice Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA Br J Haematol 96 1997 601 610 (Pubitemid 27087248)
57. M. Ichikawa, T. Asai, and T. Saito AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis Nat Med 10 2004 299 304 (Pubitemid 38667622)
58. S.W. Hiebert, W. Sun, and J.N. Davis The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription Mol Cell Biol 16 1996 1349 1355 (Pubitemid 26095605)
59. S. Tsuzuki, M. Seto, and M. Greaves Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice Proc Natl Acad Sci U S A 101 2004 8443 8448 (Pubitemid 38736594)
60. S. Raynaud, L. Mauvieux, and J.M. Cayuela TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia Leukemia 10 1996 1529 1530 (Pubitemid 26290338)
61. C.G. Mullighan, X. Su, and J. Zhang Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia N Engl J Med 360 2009 470 480
62. D. Hong, R. Gupta, and P. Ancliff Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia Science 319 2008 336 339
63. C.J. Harrison, A.V. Moorman, and K.E. Barber Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study Br J Haematol 129 2005 520 530 (Pubitemid 40769901)
64. J.C. Strefford, F.W. van Delft, and H.M. Robinson Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 Proc Natl Acad Sci U S A 103 2006 8167 8172 (Pubitemid 43801070)
65. L. Harewood, H. Robinson, and R. Harris Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases Leukemia 17 2003 547 553 (Pubitemid 36395648)
66. J. Soulier, L. Trakhtenbrot, and V. Najfeld Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup Leukemia 17 2003 1679 1682 (Pubitemid 36986978)
67. V. Rand, H. Parker, and L.J. Russell Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia Blood 117 2011 6848 6855
68. H.M. Robinson, Z.J. Broadfield, and K.L. Cheung Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome Leukemia 17 2003 2249 2250 (Pubitemid 37428400)
69. A.V. Moorman, S.M. Richards, and H.M. Robinson Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21) Blood 109 2007 2327 2330 (Pubitemid 46425871)
70. M.J. Dyer, T. Akasaka, and M. Capasso Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood 115 2010 1490 1499
71. T. Akasaka, T. Balasas, and L.J. Russell Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) Blood 109 2007 3451 3461 (Pubitemid 46572535)
72. C. Lundin, J. Heldrup, and T. Ahlgren B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome Eur J Haematol 82 2009 46 53
73. L.J. Russell, T. Akasaka, and A. Majid t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) Blood 111 2008 387 391
74. L.J. Russell, D.G. De Castro, and M. Griffiths A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin Leukemia 23 2009 614 617
75. J.C. Grimaldi, and T.C. Meeker The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene Blood 73 1989 2081 2085 (Pubitemid 19179537)
76. T. Sonoki, E. Iwanaga, and H. Mitsuya Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia Leukemia 19 2005 2009 2010 (Pubitemid 41554016)
77. E. Chapiro, L.J. Russell, and S. Struski A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia Leukemia 24 2010 1362 1364
78. K. Georgopoulos, M. Bigby, and J.H. Wang The Ikaros gene is required for the development of all lymphoid lineages Cell 79 1994 143 156 (Pubitemid 24309520)
79. S. Winandy, P. Wu, and K. Georgopoulos A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma Cell 83 1995 289 299
80. C. Virely, S. Moulin, and C. Cobaleda Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia Leukemia 24 2010 1200 1204
81. L. Sun, N. Heerema, and L. Crotty Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia Proc Natl Acad Sci U S A 96 1999 680 685 (Pubitemid 29061268)
82. L. Sun, P.A. Goodman, and C.M. Wood Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia J Clin Oncol 17 1999 3753 3766
83. K. Nakase, F. Ishimaru, and N. Avitahl Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia Cancer Res 60 2000 4062 4065 (Pubitemid 30636585)
84. K. Nishii, N. Katayama, and H. Miwa Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia Leukemia 16 2002 1285 1292
85. C.G. Mullighan, L.A. Phillips, and X. Su Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia Science 322 2008 1377 1380 (Pubitemid 352775249)
86. I. Iacobucci, C.T. Storlazzi, and D. Cilloni Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) Blood 114 2009 2159 2167
87. C.G. Mullighan, C.B. Miller, and I. Radtke BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Nature 453 2008 110 114 (Pubitemid 351630327)
88. G. Cazzaniga, F.W. van Delft, and L. Lo Nigro Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia Blood 118 2011 5559 5564
89. J. Familiades, M. Bousquet, and M. Lafage-Pochitaloff PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study Leukemia 23 2009 1989 1998
90. E. Coyaud, S. Struski, and N. Prade Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study Blood 115 2010 3089 3097
91. K. Nebral, D. Denk, and A. Attarbaschi Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia Leukemia 23 2009 134 143
92. M. Bousquet, C. Broccardo, and C. Quelen A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5 Blood 109 2007 3417 3423 (Pubitemid 46572531)
93. N. Kawamata, S. Ogawa, and M. Zimmermann Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray Blood 111 2008 776 784
94. S. Sulong, A.V. Moorman, and J.A. Irving A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups Blood 113 2009 100 107
95. K. Paulsson, J.B. Cazier, and F. Macdougall Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease Proc Natl Acad Sci U S A 105 2008 6708 6713 (Pubitemid 351754571)
96. M. Kim, S.H. Yim, and N.S. Cho Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study Cancer Genet Cytogenet 195 2009 59 65
97. D. Bercovich, I. Ganmore, and L.M. Scott Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome Lancet 372 2008 1484 1492
98. L. Kearney, D. Gonzalez De Castro, and J. Yeung Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia Blood 113 2009 646 648
99. E. Flex, V. Petrangeli, and L. Stella Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia J Exp Med 205 2008 751 758 (Pubitemid 351549874)
100. C.G. Mullighan, J. Zhang, and R.C. Harvey JAK mutations in high-risk childhood acute lymphoblastic leukemia Proc Natl Acad Sci U S A 106 2009 9414 9418
101. T. Hornakova, J. Staerk, and Y. Royer Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers J Biol Chem 284 2009 6773 6781
102. A. Pandey, K. Ozaki, and H. Baumann Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin Nat Immunol 1 2000 59 64
103. L.J. Russell, M. Capasso, and I. Vater Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia Blood 114 2009 2688 2698
104. C.G. Mullighan, J.R. Collins-Underwood, and L.A. Phillips Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia Nat Genet 41 2009 1243 1246
105. L. Hertzberg, E. Vendramini, and I. Ganmore Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group Blood 115 2010 1006 1017
106. A. Yoda, Y. Yoda, and S. Chiaretti Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia Proc Natl Acad Sci U S A 107 2010 252 257
107. E. Chapiro, L. Russell, and E. Lainey Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia Leukemia 24 2010 642 645
108. C. Shochat, N. Tal, and O.R. Bandapalli Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias J Exp Med 208 2011 901 908
109. M.T. Le, C. Teh, and N. Shyh-Chang MicroRNA-125b is a novel negative regulator of p53 Genes Dev 23 2009 862 876
110. M. Bousquet, M.H. Harris, and B. Zhou MicroRNA miR-125b causes leukemia Proc Natl Acad Sci U S A 107 2011 21558 21563
111. D. Schotte, R.X. De Menezes, and F.A. Moqadam MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia Haematologica 96 2011 703 711
112. D. Schotte, F.A. Moqadam, and E.A. Lange-Turenhout Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia Leukemia 25 2011 1389 1399
113. H. Mori, S.M. Colman, and Z. Xiao Chromosome translocations and covert leukemic clones are generated during normal fetal development Proc Natl Acad Sci U S A 99 2002 8242 8247 (Pubitemid 34651037)
114. M.K. Chuk, E. McIntyre, and D. Small Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin Blood 113 2009 6691 6694
115. C.M. Bateman, S.M. Colman, and T. Chaplin Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia Blood 115 2010 3553 3558
116. K. Anderson, C. Lutz, and F.W. van Delft Genetic variegation of clonal architecture and propagating cells in leukaemia Nature 469 2011 356 361
117. F. Notta, C.G. Mullighan, and J.C. Wang Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells Nature 469 2011 362 367
118. J. Davidsson, K. Paulsson, and D. Lindgren Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations Leukemia 24 2010 924 931
119. D. Bhojwani, H. Kang, and N.P. Moskowitz Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study Blood 108 2006 711 717 (Pubitemid 44061374)
120. M. Smith, D. Arthur, and B. Camitta Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 14 1996 18 24 (Pubitemid 26019992)
121. K.R. Schultz, D.J. Pullen, and H.N. Sather Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG) Blood 109 2007 926 935 (Pubitemid 46220635)
122. M.J. Borowitz, M. Devidas, and S.P. Hunger Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study Blood 111 2008 5477 5485
123. R. Bassan, O. Spinelli, and E. Oldani Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) Blood 113 2009 4153 4162
124. T. Muzzafar, L.J. Medeiros, and S.A. Wang Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry Am J Clin Pathol 132 2009 692 698
125. E. Coustan-Smith, G. Song, and C. Clark New markers for minimal residual disease detection in acute lymphoblastic leukemia Blood 117 2011 6267 6276
126. G. Martinelli, I. Iacobucci, and C.T. Storlazzi IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report J Clin Oncol 27 2009 5202 5207
127. R.C. Harvey, C.G. Mullighan, and X. Wang Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome Blood 116 2010 4874 4884
128. M.L. Den Boer, M. van Slegtenhorst, and R.X. De Menezes A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study Lancet Oncol 10 2009 125 134
129. H. Kang, I.M. Chen, and C.S. Wilson Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia Blood 115 2010 1394 1405
130. Z. Zuo, D. Jones, and H. Yao A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia Mod Pathol 23 2010 1524 1534
131. L.M. Kelly, and D.G. Gilliland Genetics of myeloid leukemias Annu Rev Genomics Hum Genet 3 2002 179 198 (Pubitemid 35217435)
132. F. Ravandi, S. O'Brien, and D. Thomas First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia Blood 116 2010 2070 2077